World Health Organization Raises Concern Over Critical Scarcity of Weight-Loss Injections
Under one in 10 individuals that would benefit from obesity jabs including Wegovy are able to get them, warns the global health agency as it releases its initial guidance on the medications.
With over a billion people worldwide currently living with obesity, it is advocating for more widespread and fairer availability to this class of drugs.
Per projections, more than two billion will be obese by 2030 without intervention.
"Our new guidance acknowledges that excess weight is a long-term condition that can be managed with thorough and continuous support," stated its chief Tedros Adhanom Ghebreyesus.
Significant expense, insufficient output, and supply-chain constraints are key hurdles to universal availability to the treatments that can help people shift considerable weight, says the agency.
Weight-Loss Drug Scarcity
Even in the present best projected outlook, the production of these medications would only suffice for approximately 100 million people – fewer than 10% of eligible patients, per the WHO.
The advice encourages nations and manufacturers to widen availability, by strategies such as voluntary licensing.
A patent on semaglutide – the primary component of a leading brand – is set to lapse in several nations in 2026.
The Way Weight-Loss Jabs Operate
The injections mimick a body's own hormone to delay gastric emptying, suppress the appetite and enhance the sense of being full so people consume fewer calories.
People typically see weight reduction after several weeks of commencing the weekly injections.
Evidence points to users may regain a significant portion a year later of stopping the drug, when their typical food cravings come back.
Being overweight or obese increases your likelihood for contracting medical conditions, including diabetes, cardiovascular issues, stroke, and specific malignancies.
Excess weight impacts individuals in all nations and was responsible for 3.7 million deaths worldwide in 2024, as per the WHO.
